April 10, 2009 - The Society for Cardiovascular Angiography and Interventions (SCAI) will host its annual scientific sessions May 6-9 in Las Vegas, NV.
This year’s meeting will highlight the latest research and hottest topics in interventional cardiology. Highlights will include late-breaking clinical trials, including the AMADEUS trial on percutaneous mitral valve repair and new results from The Clopidogrel Medco Outcomes Study on the effects of clopidogrel and individual PPIs. Practice-changing trials and abstracts sessions will review how the major trials of the past 12 months impact patient care, including SYNTAX, FREEDOM and others.
Keynote addresses include simplifying approval of children’s devices by Charles E. Mullins, M.D., FSCAI, what the latest studies say about utilization of angioplasty by Paul Teirstein, M.D., and the qualities that comprise professionalism in medicine by Christopher J. White, M.D., FSCAI.
The event also includes emerging technology and therapy sessions on future stent technology, percutaneous valve technology and antiplatelet drugs. Live cases will be presented on a variety of topics, including left main and bifurcation, structural heart disease, and others.
Other key themes of research to be presented include structural heart disease, radial versus femoral PCI, inpatient versus outpatient PCI, disparities between men and women, and treatment of octogenarians.
For more information: www.scai.org